Society guideline links: Primary aldosteronism

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Adrenal cancer" and "Society guideline links: Adrenal incidentaloma" and "Society guideline links: Hypertension in adults".)

International

●International histopathology consensus for unilateral primary aldosteronism (2021)

●Primary Aldosteronism Surgery Outcome (PASO) Investigators: Outcomes after adrenalectomy for unilateral primary aldosteronism – An international consensus on outcome measures and analysis of remission rates in an international cohort (2017)

●Endocrine Society (ES): Clinical practice guideline for the management of primary aldosteronism – Case detection, diagnosis, and treatment (2016)

●An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism (2014)

Canada

●Hypertension Canada: Guidelines on Diagnosis & Assessment – Section VIII: Assessment for endocrine hypertension

●Hypertension Canada: Guidelines on Prevention & Treatment – Section XIV: Treatment of secondary hypertension due to endocrine causes

Europe

●European Society of Hypertension (ESH): Position statement and consensus on genetics, prevalence, screening and confirmation of primary aldosteronism (2020)

●ESH: Position statement and consensus on subtype diagnosis, treatment, complications and outcomes of primary aldosteronism (2020)

Japan

●Japan Endocrine Society (JES): Clinical practice guideline for the diagnosis and management of primary aldosteronism 2021 (published 2022)